Rapid and parallel adaptive mutations in spike S1 drive clade success in SARS-CoV-2.


Journal

bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187

Informations de publication

Date de publication:
19 Jan 2022
Historique:
pubmed: 22 9 2021
medline: 22 9 2021
entrez: 21 9 2021
Statut: epublish

Résumé

Given the importance of variant SARS-CoV-2 viruses with altered receptor-binding or antigenic phenotypes, we sought to quantify the degree to which adaptive evolution is driving accumulation of mutations in the SARS-CoV-2 genome. Here we assessed adaptive evolution across genes in the SARS-CoV-2 genome by correlating clade growth with mutation accumulation as well as by comparing rates of nonsynonymous to synonymous divergence, clustering of mutations across the SARS-CoV-2 phylogeny and degree of convergent evolution of individual mutations. We find that spike S1 is the focus of adaptive evolution, but also identify positively-selected mutations in other genes that are sculpting the evolutionary trajectory of SARS-CoV-2. Adaptive changes in S1 accumulated rapidly, resulting in a remarkably high ratio of nonsynonymous to synonymous divergence that is 2.5X greater than that observed in HA1 at the beginning of the 2009 H1N1 pandemic.

Identifiants

pubmed: 34545361
doi: 10.1101/2021.09.11.459844
pmc: PMC8452090
pii:
doi:

Types de publication

Preprint

Langues

eng

Subventions

Organisme : NIGMS NIH HHS
ID : R35 GM119774
Pays : United States

Commentaires et corrections

Type : UpdateIn

Références

Infect Genet Evol. 2020 Sep;83:104351
pubmed: 32387564
Mol Cell. 2020 May 21;78(4):779-784.e5
pubmed: 32362314
Virus Evol. 2018 Jan 08;4(1):vex042
pubmed: 29340210
PLoS Pathog. 2021 Apr 8;17(4):e1009453
pubmed: 33831132
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6
pubmed: 33592168
J Infect. 2020 Jul;81(1):e24-e27
pubmed: 32283146
Science. 2009 Oct 30;326(5953):734-6
pubmed: 19900932
Nature. 2021 Apr;592(7855):616-622
pubmed: 33567448
Nature. 2022 Sep;609(7929):994-997
pubmed: 35952714
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Cell. 2020 Sep 3;182(5):1284-1294.e9
pubmed: 32730807
Nat Commun. 2022 Jul 20;13(1):4186
pubmed: 35859071
Science. 2021 Mar 12;371(6534):1139-1142
pubmed: 33536258
Microbiol Spectr. 2022 Aug 31;10(4):e0151422
pubmed: 35766497
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142653
Elife. 2021 Jan 19;10:
pubmed: 33463525
Nature. 1991 Jun 20;351(6328):652-4
pubmed: 1904993
Proc Natl Acad Sci U S A. 2021 Jul 20;118(29):
pubmed: 34292871
Nature. 2022 Mar;603(7902):679-686
pubmed: 35042229
Science. 2004 Jul 16;305(5682):371-6
pubmed: 15218094
Nat Commun. 2021 May 11;12(1):2642
pubmed: 33976134
Nat Commun. 2021 May 11;12(1):2697
pubmed: 33976229
Nature. 2022 Feb;602(7898):654-656
pubmed: 35016196
J Open Source Softw. 2021;6(57):
pubmed: 34189396
Biol Direct. 2006 Oct 26;1:34
pubmed: 17067369
Elife. 2014;3:e01914
pubmed: 24497547
Nat Commun. 2015 Aug 06;6:7952
pubmed: 26245473
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Microbiol. 2021 Jul;6(7):821-823
pubmed: 34108654
Cell Rep. 2020 Oct 6;33(1):108234
pubmed: 32979938
Cell. 2020 Sep 3;182(5):1295-1310.e20
pubmed: 32841599
Cell Rep. 2022 May 17;39(7):110829
pubmed: 35550680
Cell. 2021 Sep 30;184(20):5189-5200.e7
pubmed: 34537136
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
PLoS Biol. 2020 Jun 8;18(6):e3000715
pubmed: 32511245

Auteurs

Kathryn E Kistler (KE)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Molecular and Cellular Biology Program, University of Washington, Seattle, WA, United States.

John Huddleston (J)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.

Trevor Bedford (T)

Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States.
Molecular and Cellular Biology Program, University of Washington, Seattle, WA, United States.
Howard Hughes Medical Institute, Seattle, WA, United States.

Classifications MeSH